Entruity Wealth LLC acquired a new stake in shares of The Procter & Gamble Company (NYSE:PG - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,098 shares of the company's stock, valued at approximately $352,000.
Other institutional investors have also modified their holdings of the company. Sagespring Wealth Partners LLC bought a new stake in Procter & Gamble in the fourth quarter worth about $7,721,000. Townsquare Capital LLC lifted its stake in shares of Procter & Gamble by 11.6% during the 4th quarter. Townsquare Capital LLC now owns 132,662 shares of the company's stock worth $22,241,000 after acquiring an additional 13,836 shares during the last quarter. Distillate Capital Partners LLC purchased a new position in Procter & Gamble during the 4th quarter valued at $42,431,000. Nicolet Bankshares Inc. grew its position in Procter & Gamble by 1.0% in the 4th quarter. Nicolet Bankshares Inc. now owns 19,585 shares of the company's stock valued at $3,283,000 after acquiring an additional 199 shares during the last quarter. Finally, Manhattan West Asset Management LLC increased its stake in Procter & Gamble by 3.2% in the fourth quarter. Manhattan West Asset Management LLC now owns 31,579 shares of the company's stock worth $5,294,000 after purchasing an additional 969 shares during the period. 65.77% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on PG. Piper Sandler lowered their target price on shares of Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating for the company in a research note on Monday, February 24th. Royal Bank of Canada reissued a "sector perform" rating and issued a $164.00 price objective on shares of Procter & Gamble in a research report on Thursday, January 23rd. Erste Group Bank raised shares of Procter & Gamble from a "hold" rating to a "strong-buy" rating in a research report on Monday, March 17th. JPMorgan Chase & Co. dropped their price objective on Procter & Gamble from $181.00 to $172.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Finally, Barclays restated an "equal weight" rating on shares of Procter & Gamble in a report on Thursday, March 27th. Seven analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have given a strong buy rating to the company's stock. According to data from MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and an average target price of $181.50.
View Our Latest Research Report on Procter & Gamble
Insider Activity
In related news, insider Marc S. Pritchard sold 90,450 shares of the firm's stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the completion of the transaction, the insider now owns 172,814 shares of the company's stock, valued at $28,313,845.76. This trade represents a 34.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Gary A. Coombe sold 18,000 shares of the stock in a transaction dated Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total value of $3,089,880.00. Following the sale, the chief executive officer now directly owns 22,051 shares in the company, valued at $3,785,274.66. This represents a 44.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 143,450 shares of company stock valued at $23,988,008. Company insiders own 0.18% of the company's stock.
Procter & Gamble Stock Down 1.3 %
Procter & Gamble stock traded down $2.15 during midday trading on Wednesday, reaching $166.32. The company's stock had a trading volume of 5,897,469 shares, compared to its average volume of 8,140,057. The Procter & Gamble Company has a 52-week low of $153.52 and a 52-week high of $180.43. The stock has a market capitalization of $390.00 billion, a P/E ratio of 26.48, a PEG ratio of 3.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The stock's 50-day simple moving average is $168.34 and its 200-day simple moving average is $168.56.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The company had revenue of $21.88 billion for the quarter, compared to the consensus estimate of $21.66 billion. During the same quarter in the previous year, the firm earned $1.84 EPS. Procter & Gamble's revenue was up 2.1% compared to the same quarter last year. On average, sell-side analysts expect that The Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Monday, April 21st will be paid a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.54%. The ex-dividend date is Monday, April 21st. This is an increase from Procter & Gamble's previous quarterly dividend of $1.01. Procter & Gamble's payout ratio is presently 67.20%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report